Mexico Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032

Mexico Point-of-Care Glucose Testing Market

Mexico is observing rapid growth in the Point-of-Care Glucose Testing market. The raising prevalence of diabetic issues, increasing senior citizen populace as well as developments in medical care infrastructure throughout the country are the significant drivers of the marketplace. Moreover, climbing investment by key players for item development and technological development are likewise anticipated to drive the market growth. According to the World Wellness Organization, Mexico has the 2nd greatest diabetic issues prevalence rate in the Americas, after the United States.

 

The Mexico point-of-care glucose testing market is segmented into product type, application, and end user. On the basis of product type, the market is bifurcated into lancing devices & strips and blood-glucose meter. The Test strips segment held the major market share across the global point-of-care glucose testing market in 2019 and is prepared to grow at a consistent price during the forecast duration. Based on application, the market is segregated into type-1 diabetes and type-2 diabetes. By end user, the market is categorized into hospitals & clinics, home care settings, and others.

The major factor driving the market is the boosting occurrence of diabetic issues worldwide. As per the Globe Health Company, the estimated occurrence of diabetic issues worldwide was 425 million in 2017 and also is expected to expand yearly. With the increasing frequency of diabetes mellitus, the need for point-of-care glucose testing gadgets gets on the increase, hence promoting the development of the Mexico point-of-care glucose testing market. The high cost of the devices might interfere with the marketplace growth. Additionally, absence of awareness among the people in country and remote areas have actually been the major restraints in the growth of the marketplace. Boosting investment in the medical care field in Mexico, rising demand for point-of-care glucose testing tools, and expanding understanding concerning the gadget in backwoods supplies a chances for the marketplace gamers.

 

The hazard of brand-new participants is relatively low due to the relatively small market dimension and also the visibility of large business currently dominating the market. Haggling power of purchasers and also suppliers is moderate, as there are few purchasers as well as vendors in the marketplace. The competition in the marketplace is growing as a result of the access of brand-new gamers. The danger of alternatives is reduced due to the one-of-a-kind advantages of point-of-care sugar screening gadgets. The overall intensity of affordable competition is high because of the presence of many market players.

 

The Mexico point-of-care glucose testing market is likely to experience enhanced need in the coming years owing to the growing requirement for exact testing options. Moreover, innovations in innovation such as the introduction of mobile healthcare applications and also mobile glucose monitoring devices are anticipated to further drive the marketplace. Business in the marketplace are also anticipated to concentrate on developing ingenious options to make sugar screening much easier as well as more exact. Furthermore, firms are likewise most likely to focus on increasing their geographical existence to tap into the untapped potential in the remote locations of the country. Furthermore, federal government efforts such as offering aids and tax obligation rebates to diabetes mellitus people are likely to more propel the uptake of these modern technologies.

Emerging markets in the Mexico point-of-care glucose testing market such as mobile-based applications for non-invasive sugar testing are raising. With the appearance of mobile applications, the very easy accessibility of information for remote areas is raising. Additionally, climbing fostering of clever glucose monitoring devices and also enhancing financial investments by key players in R & D are anticipated to drive the market development. The Ministry of Wellness in Mexico is constructing standards for the monitoring of diabetes.

Additionally, the government is giving prescription compensation for Point-of-Care Glucose Evaluating to make certain the schedule of tools for individuals staying in remote locations. On the basis of completion user, the market is categorized right into medical facilities and facilities, house care settings, and also others. Out of these, the healthcare facilities as well as facilities sector holds the significant market share. This can be credited to the boosting number of diabetic issues patients requiring normal glucose testing. The Mexico point-of-care glucose testing market is very affordable in nature. Roche, Abbott, Bayer, Siemens Healthineers, Sysmex, Nova Biomedical, LipoScience, Acon Laboratories, Trinity Biotech and Hycel Medicals are a few of the major firms running in this market.

Roche has partnered with NIPRO Medical Company to give options for diabetes mellitus screening. The partnership gives the firm with a chance to increase its offerings for diabetes mellitus and provides a personalized service for diabetes. Abbott has actually introduced the Afinion ™ 2 Analyzer that aids doctors to get the quickest and also precise result from a one-step dimension test. Bayer has developed a brand-new analysis meter the Shape ® Next Link 2.4 meter that simplifies to move diabetic issues analyses to individuals' health care experts online. Siemens Healthineers has established a new series of blood glucose surveillance tools, the Standard Blood Sugar Monitoring (BGMS) range which is created to meet the needs of both healthcare specialists and house users. Sysmex unveiled a new tool, BioDireX, to help with personal diabetes mellitus treatment.

Key Players

○ Roche
○ Abbott
○ Bayer
○ Siemens Healthineers
○ Sysmex
○ Nova Biomedical
○ LipoScience
○ Acon Laboratories
○ Trinity Biotech

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

● Product Benchmarking / Product specification and applications

○ Hycel Medical

Scope of Mexico Point-of-Care Glucose Testing Market Report

1.1. Report Description

1.2. Key Market Segments

1.3. Key Benefits to the Stakeholders

1.4. Research Methodology

1.4.1. Primary Research

1.4.2. Secondary Research

1.4.3. Analyst Tools and Models

2.1. CXO Perspective

3.1. Market Definition and Scope

3.2. Key Findings

3.2.1. Top Impacting Factors

3.2.2. Top Investment Pockets

3.3. Porter’s Five Forces Analysis

3.4. Market Dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market Size and Forecast, By Product Type

4.2. Lancing Devices and Strips

4.3. Blood-Glucose Meter

5.1. Overview

5.1.1. Market Size and Forecast, By Application

5.2. Type-1 Diabetes

5.3. Type-2 Diabetes

6.1. Overview

6.1.1. Market Size and Forecast, By End User

6.2. Hospitals and Clinics

6.3. Home Care Settings

6.4. Others

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Top player positioning, 2022

8.1. Roche

8.1.1. Company overview

8.1.2. Key Executives

8.1.3. Company snapshot

8.1.4. Operating business segments

8.1.5. Product portfolio

8.1.6. Business performance

8.1.7. Key strategic moves and developments

8.2. Abbott

8.2.1. Company overview

8.2.2. Key Executives

8.2.3. Company snapshot

8.2.4. Operating business segments

8.2.5. Product portfolio

8.2.6. Business performance

8.2.7. Key strategic moves and developments

8.3. Bayer

8.3.1. Company overview

8.3.2. Key Executives

8.3.3. Company snapshot

8.3.4. Operating business segments

8.3.5. Product portfolio

8.3.6. Business performance

8.3.7. Key strategic moves and developments

8.4. Siemens Healthineers

8.4.1. Company overview

8.4.2. Key Executives

8.4.3. Company snapshot

8.4.4. Operating business segments

8.4.5. Product portfolio

8.4.6. Business performance

8.4.7. Key strategic moves and developments

8.5. Sysmex

8.5.1. Company overview

8.5.2. Key Executives

8.5.3. Company snapshot

8.5.4. Operating business segments

8.5.5. Product portfolio

8.5.6. Business performance

8.5.7. Key strategic moves and developments

8.6. Nova Biomedical

8.6.1. Company overview

8.6.2. Key Executives

8.6.3. Company snapshot

8.6.4. Operating business segments

8.6.5. Product portfolio

8.6.6. Business performance

8.6.7. Key strategic moves and developments

8.7. LipoScience

8.7.1. Company overview

8.7.2. Key Executives

8.7.3. Company snapshot

8.7.4. Operating business segments

8.7.5. Product portfolio

8.7.6. Business performance

8.7.7. Key strategic moves and developments

8.8. Acon Laboratories

8.8.1. Company overview

8.8.2. Key Executives

8.8.3. Company snapshot

8.8.4. Operating business segments

8.8.5. Product portfolio

8.8.6. Business performance

8.8.7. Key strategic moves and developments

8.9. Trinity Biotech

8.9.1. Company overview

8.9.2. Key Executives

8.9.3. Company snapshot

8.9.4. Operating business segments

8.9.5. Product portfolio

8.9.6. Business performance

8.9.7. Key strategic moves and developments

8.10. Hycel Medicals

8.10.1. Company overview

8.10.2. Key Executives

8.10.3. Company snapshot

8.10.4. Operating business segments

8.10.5. Product portfolio

8.10.6. Business performance

8.10.7. Key strategic moves and development

LIST OF TABLES

TABLE 01. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 02. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 03. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 04. ROCHE: KEY EXECUTIVES

TABLE 05. ROCHE: COMPANY SNAPSHOT

TABLE 06. ROCHE: OPERATING SEGMENTS

TABLE 07. ROCHE: PRODUCT PORTFOLIO

TABLE 08. ROCHE: KEY STRATERGIES

TABLE 09. ABBOTT: KEY EXECUTIVES

TABLE 10. ABBOTT: COMPANY SNAPSHOT

TABLE 11. ABBOTT: OPERATING SEGMENTS

TABLE 12. ABBOTT: PRODUCT PORTFOLIO

TABLE 13. ABBOTT: KEY STRATERGIES

TABLE 14. BAYER: KEY EXECUTIVES

TABLE 15. BAYER: COMPANY SNAPSHOT

TABLE 16. BAYER: OPERATING SEGMENTS

TABLE 17. BAYER: PRODUCT PORTFOLIO

TABLE 18. BAYER: KEY STRATERGIES

TABLE 19. SIEMENS HEALTHINEERS: KEY EXECUTIVES

TABLE 20. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

TABLE 21. SIEMENS HEALTHINEERS: OPERATING SEGMENTS

TABLE 22. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO

TABLE 23. SIEMENS HEALTHINEERS: KEY STRATERGIES

TABLE 24. SYSMEX: KEY EXECUTIVES

TABLE 25. SYSMEX: COMPANY SNAPSHOT

TABLE 26. SYSMEX: OPERATING SEGMENTS

TABLE 27. SYSMEX: PRODUCT PORTFOLIO

TABLE 28. SYSMEX: KEY STRATERGIES

TABLE 29. NOVA BIOMEDICAL: KEY EXECUTIVES

TABLE 30. NOVA BIOMEDICAL: COMPANY SNAPSHOT

TABLE 31. NOVA BIOMEDICAL: OPERATING SEGMENTS

TABLE 32. NOVA BIOMEDICAL: PRODUCT PORTFOLIO

TABLE 33. NOVA BIOMEDICAL: KEY STRATERGIES

TABLE 34. LIPOSCIENCE: KEY EXECUTIVES

TABLE 35. LIPOSCIENCE: COMPANY SNAPSHOT

TABLE 36. LIPOSCIENCE: OPERATING SEGMENTS

TABLE 37. LIPOSCIENCE: PRODUCT PORTFOLIO

TABLE 38. LIPOSCIENCE: KEY STRATERGIES

TABLE 39. ACON LABORATORIES: KEY EXECUTIVES

TABLE 40. ACON LABORATORIES: COMPANY SNAPSHOT

TABLE 41. ACON LABORATORIES: OPERATING SEGMENTS

TABLE 42. ACON LABORATORIES: PRODUCT PORTFOLIO

TABLE 43. ACON LABORATORIES: KEY STRATERGIES

TABLE 44. TRINITY BIOTECH: KEY EXECUTIVES

TABLE 45. TRINITY BIOTECH: COMPANY SNAPSHOT

TABLE 46. TRINITY BIOTECH: OPERATING SEGMENTS

TABLE 47. TRINITY BIOTECH: PRODUCT PORTFOLIO

TABLE 48. TRINITY BIOTECH: KEY STRATERGIES

TABLE 49. HYCEL MEDICALS: KEY EXECUTIVES

TABLE 50. HYCEL MEDICALS: COMPANY SNAPSHOT

TABLE 51. HYCEL MEDICALS: OPERATING SEGMENTS

TABLE 52. HYCEL MEDICALS: PRODUCT PORTFOLIO

TABLE 53. HYCEL MEDICALS: KEY STRATERGIES LIST OF FIGURES

FIGURE 01. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032

FIGURE 03. TOP INVESTMENT POCKETS IN MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)

FIGURE 04. PORTER FIVE-1

FIGURE 05. PORTER FIVE-2

FIGURE 06. PORTER FIVE-3

FIGURE 07. PORTER FIVE-4

FIGURE 08. PORTER FIVE-5

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET

FIGURE 10. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)

FIGURE 11. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)

FIGURE 12. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)

FIGURE 13. TOP WINNING STRATEGIES, BY YEAR

FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 17. COMPETITIVE DASHBOARD

FIGURE 18. COMPETITIVE HEATMAP: MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET

FIGURE 19. TOP PLAYER POSITIONING, 2022

FIGURE 20. ROCHE: NET SALES, 2020-2022* ($MILLION)

FIGURE 21. ROCHE: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 22. ROCHE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 23. ABBOTT: NET SALES, 2020-2022* ($MILLION)

FIGURE 24. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 25. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 26. BAYER: NET SALES, 2020-2022* ($MILLION)

FIGURE 27. BAYER: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 28. BAYER: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 29. SIEMENS HEALTHINEERS: NET SALES, 2020-2022* ($MILLION)

FIGURE 30. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 31. SIEMENS HEALTHINEERS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 32. SYSMEX: NET SALES, 2020-2022* ($MILLION)

FIGURE 33. SYSMEX: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 34. SYSMEX: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 35. NOVA BIOMEDICAL: NET SALES, 2020-2022* ($MILLION)

FIGURE 36. NOVA BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 37. NOVA BIOMEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 38. LIPOSCIENCE: NET SALES, 2020-2022* ($MILLION)

FIGURE 39. LIPOSCIENCE: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 40. LIPOSCIENCE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 41. ACON LABORATORIES: NET SALES, 2020-2022* ($MILLION)

FIGURE 42. ACON LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 43. ACON LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 44. TRINITY BIOTECH: NET SALES, 2020-2022* ($MILLION)

FIGURE 45. TRINITY BIOTECH: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 46. TRINITY BIOTECH: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

FIGURE 47. HYCEL MEDICALS: NET SALES, 2020-2022* ($MILLION)

FIGURE 48. HYCEL MEDICALS: REVENUE SHARE, BY SEGMENT, 2022 (%)

FIGURE 49. HYCEL MEDICALS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%